Metabolic Impacts of Ren-Nu: A Dietary Program for Polycystic Kidney Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Metabolic Impacts of Ren-Nu: A Dietary Program for Polycystic Kidney Disease — Stella

Recruiting

Back to Autosomal Dominant Polycystic Kidney Disease (ADPKD) trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Cleveland Clinic, Cleveland, Ohio

Key details

Sponsor

Richard Fatica

Collaborators

Santa Barbara Nutrients

Enrollment target

~20 participants

Started

February 2026

Primary completion

February 2027

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov